Logo image of PTX.DE

PALANTIR TECHNOLOGIES INC-A (PTX.DE) Stock Fundamental Analysis

FRA:PTX - US69608A1088 - Common Stock

135.5 EUR
+2.62 (+1.97%)
Last: 9/2/2025, 5:29:59 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PTX. PTX was compared to 108 industry peers in the Software industry. PTX has an excellent financial health rating, but there are some minor concerns on its profitability. PTX is valued quite expensive, but it does show an excellent growth. These ratings could make PTX a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year PTX was profitable.
PTX had a positive operating cash flow in the past year.
In multiple years PTX reported negative net income over the last 5 years.
Of the past 5 years PTX 4 years had a positive operating cash flow.
PTX.DE Yearly Net Income VS EBIT VS OCF VS FCFPTX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

Looking at the Return On Assets, with a value of 10.36%, PTX belongs to the top of the industry, outperforming 87.04% of the companies in the same industry.
The Return On Equity of PTX (12.87%) is better than 66.67% of its industry peers.
PTX's Return On Invested Capital of 6.39% is fine compared to the rest of the industry. PTX outperforms 60.19% of its industry peers.
Industry RankSector Rank
ROA 10.36%
ROE 12.87%
ROIC 6.39%
ROA(3y)0.38%
ROA(5y)-11.69%
ROE(3y)0.24%
ROE(5y)-19.79%
ROIC(3y)N/A
ROIC(5y)N/A
PTX.DE Yearly ROA, ROE, ROICPTX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

PTX has a better Profit Margin (22.18%) than 83.33% of its industry peers.
PTX has a better Operating Margin (16.55%) than 72.22% of its industry peers.
PTX's Gross Margin of 80.03% is fine compared to the rest of the industry. PTX outperforms 68.52% of its industry peers.
In the last couple of years the Gross Margin of PTX has grown nicely.
Industry RankSector Rank
OM 16.55%
PM (TTM) 22.18%
GM 80.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.96%
GM growth 5Y3.56%
PTX.DE Yearly Profit, Operating, Gross MarginsPTX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PTX is destroying value.
Compared to 1 year ago, PTX has more shares outstanding
The number of shares outstanding for PTX has been increased compared to 5 years ago.
PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PTX.DE Yearly Shares OutstandingPTX.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
PTX.DE Yearly Total Debt VS Total AssetsPTX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

PTX has an Altman-Z score of 154.94. This indicates that PTX is financially healthy and has little risk of bankruptcy at the moment.
PTX has a Altman-Z score of 154.94. This is amongst the best in the industry. PTX outperforms 99.07% of its industry peers.
PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 154.94
ROIC/WACC0.57
WACC11.28%
PTX.DE Yearly LT Debt VS Equity VS FCFPTX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

PTX has a Current Ratio of 6.32. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.32, PTX belongs to the top of the industry, outperforming 89.81% of the companies in the same industry.
PTX has a Quick Ratio of 6.32. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PTX (6.32) is better than 89.81% of its industry peers.
Industry RankSector Rank
Current Ratio 6.32
Quick Ratio 6.32
PTX.DE Yearly Current Assets VS Current LiabilitesPTX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

10

3. Growth

3.1 Past

PTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.63%, which is quite impressive.
PTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.07% yearly.
PTX shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.79%.
The Revenue has been growing by 31.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)65.63%
EPS 3Y43.07%
EPS 5YN/A
EPS Q2Q%77.78%
Revenue 1Y (TTM)38.79%
Revenue growth 3Y22.95%
Revenue growth 5Y31.01%
Sales Q2Q%48.01%

3.2 Future

The Earnings Per Share is expected to grow by 40.49% on average over the next years. This is a very strong growth
Based on estimates for the next years, PTX will show a very strong growth in Revenue. The Revenue will grow by 39.19% on average per year.
EPS Next Y59.54%
EPS Next 2Y44.98%
EPS Next 3Y42.81%
EPS Next 5Y40.49%
Revenue Next Year47.31%
Revenue Next 2Y40.91%
Revenue Next 3Y38.51%
Revenue Next 5Y39.19%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PTX.DE Yearly Revenue VS EstimatesPTX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B
PTX.DE Yearly EPS VS EstimatesPTX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 301.11, the valuation of PTX can be described as expensive.
PTX's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.13, PTX is valued quite expensively.
With a Price/Forward Earnings ratio of 184.21, PTX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PTX indicates a slightly more expensive valuation: PTX is more expensive than 62.96% of the companies listed in the same industry.
PTX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 301.11
Fwd PE 184.21
PTX.DE Price Earnings VS Forward Price EarningsPTX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

PTX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PTX is more expensive than 65.74% of the companies in the same industry.
PTX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 220.3
EV/EBITDA 598.99
PTX.DE Per share dataPTX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PTX does not grow enough to justify the current Price/Earnings ratio.
PTX has a very decent profitability rating, which may justify a higher PE ratio.
PTX's earnings are expected to grow with 42.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.06
PEG (5Y)N/A
EPS Next 2Y44.98%
EPS Next 3Y42.81%

0

5. Dividend

5.1 Amount

PTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PALANTIR TECHNOLOGIES INC-A

FRA:PTX (9/2/2025, 5:29:59 PM)

135.5

+2.62 (+1.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners55.78%
Inst Owner ChangeN/A
Ins Owners3.59%
Ins Owner ChangeN/A
Market Cap321.32B
Analysts67.1
Price Target128.06 (-5.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.64%
Min EPS beat(2)-0.58%
Max EPS beat(2)13.85%
EPS beat(4)3
Avg EPS beat(4)11.44%
Min EPS beat(4)-0.58%
Max EPS beat(4)24.07%
EPS beat(8)7
Avg EPS beat(8)10.07%
EPS beat(12)9
Avg EPS beat(12)9%
EPS beat(16)10
Avg EPS beat(16)-6.83%
Revenue beat(2)2
Avg Revenue beat(2)2.56%
Min Revenue beat(2)0.43%
Max Revenue beat(2)4.7%
Revenue beat(4)4
Avg Revenue beat(4)2.71%
Min Revenue beat(4)0.43%
Max Revenue beat(4)4.7%
Revenue beat(8)5
Avg Revenue beat(8)1.2%
Revenue beat(12)6
Avg Revenue beat(12)0.7%
Revenue beat(16)7
Avg Revenue beat(16)0.44%
PT rev (1m)36.11%
PT rev (3m)51.27%
EPS NQ rev (1m)17.71%
EPS NQ rev (3m)21.36%
EPS NY rev (1m)10.6%
EPS NY rev (3m)12.34%
Revenue NQ rev (1m)11.07%
Revenue NQ rev (3m)15.26%
Revenue NY rev (1m)6.05%
Revenue NY rev (3m)6.56%
Valuation
Industry RankSector Rank
PE 301.11
Fwd PE 184.21
P/S 109.41
P/FCF 220.3
P/OCF 217.63
P/B 63.49
P/tB 63.49
EV/EBITDA 598.99
EPS(TTM)0.45
EY0.33%
EPS(NY)0.74
Fwd EY0.54%
FCF(TTM)0.62
FCFY0.45%
OCF(TTM)0.62
OCFY0.46%
SpS1.24
BVpS2.13
TBVpS2.13
PEG (NY)5.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.36%
ROE 12.87%
ROCE 9.07%
ROIC 6.39%
ROICexc 145.47%
ROICexgc 145.47%
OM 16.55%
PM (TTM) 22.18%
GM 80.03%
FCFM 49.66%
ROA(3y)0.38%
ROA(5y)-11.69%
ROE(3y)0.24%
ROE(5y)-19.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.96%
GM growth 5Y3.56%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 74.03%
Cap/Sales 0.61%
Interest Coverage 250
Cash Conversion 289.33%
Profit Quality 223.86%
Current Ratio 6.32
Quick Ratio 6.32
Altman-Z 154.94
F-Score6
WACC11.28%
ROIC/WACC0.57
Cap/Depr(3y)87.68%
Cap/Depr(5y)87.2%
Cap/Sales(3y)1.07%
Cap/Sales(5y)1.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.63%
EPS 3Y43.07%
EPS 5YN/A
EPS Q2Q%77.78%
EPS Next Y59.54%
EPS Next 2Y44.98%
EPS Next 3Y42.81%
EPS Next 5Y40.49%
Revenue 1Y (TTM)38.79%
Revenue growth 3Y22.95%
Revenue growth 5Y31.01%
Sales Q2Q%48.01%
Revenue Next Year47.31%
Revenue Next 2Y40.91%
Revenue Next 3Y38.51%
Revenue Next 5Y39.19%
EBIT growth 1Y95.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.07%
EBIT Next 3Y42.87%
EBIT Next 5Y13.24%
FCF growth 1Y355.23%
FCF growth 3Y52.59%
FCF growth 5YN/A
OCF growth 1Y328.76%
OCF growth 3Y51.19%
OCF growth 5YN/A